↓ Skip to main content

Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma

Overview of attention for article published in Clinical Sarcoma Research, January 2015
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
Published in
Clinical Sarcoma Research, January 2015
DOI 10.1186/s13569-014-0020-9
Pubmed ID
Authors

Vincent I Poon, Michael Roth, Sajida Piperdi, David Geller, Jonathan Gill, Erin R Rudzinski, Douglas S Hawkins, Richard Gorlick

Abstract

Osteosarcoma is the most common primary malignant bone tumor in children and young adults. Ganglioside GD2 has been previously found on the cell surface in various tumor types, including osteosarcomas.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 22%
Student > Ph. D. Student 6 13%
Student > Bachelor 6 13%
Professor 3 7%
Other 3 7%
Other 8 18%
Unknown 9 20%
Readers by discipline Count As %
Medicine and Dentistry 15 33%
Immunology and Microbiology 6 13%
Biochemistry, Genetics and Molecular Biology 3 7%
Agricultural and Biological Sciences 2 4%
Business, Management and Accounting 1 2%
Other 8 18%
Unknown 10 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2015.
All research outputs
#17,737,508
of 22,778,347 outputs
Outputs from Clinical Sarcoma Research
#75
of 104 outputs
Outputs of similar age
#241,713
of 351,991 outputs
Outputs of similar age from Clinical Sarcoma Research
#4
of 4 outputs
Altmetric has tracked 22,778,347 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 104 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,991 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.